KCCure Kidney Cancer Research Grant Program

KCCure Kidney Cancer Research Grant Program

KCCure Evidence Based, Patient Driven Kidney Cancer Research Grants

A core feature of our mission is to engage with the patient community to identify kidney cancer research priorities and ensure that research grant funding is geared toward filling those gaps.

KCCure Kidney Cancer Research Process

All grant proposals go through a rigorous peer review process aimed at identifying the best and most promising research that will provide the greatest opportunity to advance the understanding of kidney cancer and improve management and treatment of the disease

KCCure Kidney Cancer Scientific Advisory Board

Our scientific advisory board is made up of the top leaders in the field of kidney cancer research; including leaders from both of the NCI designated Kidney Cancer Specialized Programs of Research Excellence (Spore), leaders in the field of medical oncology, urological oncology, pathology, basic research and pyscho-oncology.

KCCure Kidney Cancer Patient Advisory Board

Our patient advisory board is comprised of leaders in the kidney cancer patient advocacy community who represent rare subtypes of kidney cancer, including renal medullary carcinoma, translocation carcinoma, and papillary carcinoma, as well as those representing patients from different locations and demographics.  KCCure advisory board members can be found representing patients throughout the country on a variety of boards including: the Patient-Centered Outcomes Research Institute (PCORI) ambassador program, the Alliance Cooperative Group, the Southwest Oncology Cooperative Group, the NCI GU Steering Committee, the Society for Immunotherapy Renal Cell Guidelines Panel, and the CDMRP Kidney Cancer Research Program Programmatic Panel.

KCCure Innovation Awards

In 2017, KCCure announced the innaugural Kidney Cancer Innovation Research Grant Award for cutting edge, innovative scientific research in kidney cancer.

Since then, $400,000 in Innovation Research Grants have been awarded to top institutions including Dana Farber, MD Anderson, UTSouthwestern, the University of North Carolina, the National Cancer Institute, and Thomas Jefferson University.

For 2021, the KCCure Research Grant Program will be expanded to include awards driving research toward needed gap areas set by the patient communities we represent.

This is an exciting step in our effort to be a truly patient-driven, evidence based kidney cancer advocacy organization.

2017 Innovation Award Winner – Wayne A. Marasco, MD, PhD, Dana-Farber Cancer Institute, Harvard Medical School. CAR T Cell Factories that Change the Tumor Microenvironment to Achieve RCC Cures.

2018 Innovation Award Winner – Qing Zhang, MD, PhD, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill. TBK1 Serves as a Novel Therapeutic Target in Kidney Cancer with VHL Loss.

For more information:

Information about new awards will be updated here as RFPs are released. If you’re a researcher and you’d like to discuss funding opportunities with KCCure, contact us at grants@kccure.org.

Lost Password


Subscribe for updates!